首页>
外国专利>
Use of pharmaceutical composition having enantiomer of tritoqualine and proton pump inhibitor to treat digestive inflammatory conditions e.g. gastric ulcer, gastritis, duodenitis, dyspepsia, oesophagitis and gastro-oesophageal reflux
Use of pharmaceutical composition having enantiomer of tritoqualine and proton pump inhibitor to treat digestive inflammatory conditions e.g. gastric ulcer, gastritis, duodenitis, dyspepsia, oesophagitis and gastro-oesophageal reflux
Use of a pharmaceutical composition having enantiomer of (amino-7-triethoxy-4,5,6-oxo-1-dihydro-1,3-isobenzofurannyl-3)-1-methoxy-8 methyl-2-methylenedioxy-6-6,7-tetrahydro-2,3,4-isoquinoline (tritoqualine) or its salts and a proton pump inhibitor (PPI) to make a drug to treat digestive inflammatory conditions, particularly diseases related to hypersecretion of digestive juices, e.g. gastritis, gastric ulcer, gastro-oesophageal reflux, oesophagitis, duodenitis, dyspepsia, particularly irritable colon syndrome. This anti-secretory composition reduces all carcinogenic risks and infections. ACTIVITY : Anti-inflammatory; Antiallergic; Immunosuppressive; Gastrointestinal-Gen; Antiulcer. MECHANISM OF ACTION : None given.
展开▼
